HomeCRL • NYSE
add
Charles River Lbrtrs ntrntl Inc
$223.15
Makalipas ang Oras ng Trabaho:(0.00%)0.00
$223.15
Sarado: Hul 17, 4:09:05 PM GMT-4 · USD · NYSE · Disclaimer
Nakaraang pagsara
$227.31
Sakop ng araw
$223.03 - $231.39
Sakop ng taon
$161.65 - $275.00
Market cap
11.49B USD
Average na Volume
476.73K
P/E ratio
26.18
Dividend yield
-
Primary exchange
NYSE
Mga Financial
Income Statement
Kita
Net na kita
(USD) | Mar 2024info | Y/Y na pagbabago |
---|---|---|
Kita | 1.01B | -1.73% |
Gastos sa pagpapatakbo | 209.59M | 0.46% |
Net na kita | 72.96M | -29.26% |
Net profit margin | 7.21 | -28.04% |
Kita sa bawat share | 2.27 | -18.35% |
EBITDA | 228.53M | -8.31% |
Aktuwal na % ng binabayarang buwis | 24.77% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
(USD) | Mar 2024info | Y/Y na pagbabago |
---|---|---|
Cash at mga panandaliang investment | 327.04M | 62.23% |
Kabuuang asset | 8.15B | 5.89% |
Kabuuang sagutin | 4.45B | -2.06% |
Kabuuang equity | 3.70B | — |
Natitirang share | 51.51M | — |
Presyo para makapag-book | 3.22 | — |
Return on assets | 4.38% | — |
Return on capital | 5.27% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y na pagbabago |
---|---|---|
Net na kita | 72.96M | -29.26% |
Cash mula sa mga operasyon | 129.89M | 18.75% |
Cash mula sa pag-invest | -85.79M | 49.12% |
Cash mula sa financing | 18.35M | -27.32% |
Net change in cash | 54.06M | 267.23% |
Malayang cash flow | 38.88M | 200.52% |
Tungkol
Charles River Laboratories International, Inc., is an American pharmaceutical company specializing in a variety of preclinical and clinical laboratory, gene therapy and cell therapy services for the pharmaceutical, medical device and biotechnology industries. It also supplies assorted biomedical products, outsourcing services, and animals for research and development in the pharmaceutical industry and offers support in the fields of basic research, drug discovery, safety and efficacy, clinical support, and manufacturing.
According to the company, it supported the development of approximately 85% of novel FDA-approved drugs in 2021.
Its customers include leading pharmaceutical, biotechnology, agrochemical, government, and academic organization around the globe. The company has over 90 facilities, operates in 20 countries, and employs approximately 18,400 people worldwide.
Charles River Laboratories is often criticized by animal rights activists who condemn the company's usage of dogs and non-human primates for pharmaceutical purposes. The company is also a major harvester of horseshoe crab blood. Wikipedia
Itinatag
1947
Headquarters
Website
Mga Empleyado
21,100